Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amosartan Efficacy and Safety in Essential Hypertension
NCT00940667Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- May 2008
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Amosartan in essential hypertension, sponsored by Hanmi Pharmaceutical. Started May 2008; status: completed.
02
Drugs
Amosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00940667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940667.